| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | +14.2% |
| Cost of Revenue | $2.9M | +67.0% |
| Gross Profit | $4.3M | -6.2% |
| R&D Expense | $32.1M | +26.4% |
| SG&A Expense | $21.5M | +81.0% |
| Operating Income | -$59.5M | -52.7% |
| Pre-tax Income | -$53.7M | -70.2% |
| Net Income | -$53.7M | -70.2% |
| EPS (Basic) | -$0.45 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $757K | +79.8% |
| Inventory | $2.2M | +3.9% |
| Current Assets | $13.9M | -27.3% |
| Total Assets | $26.9M | -17.4% |
| Current Liabilities | $16.0M | +55.8% |
| Long-term Debt | $31.2M | +150.3% |
| Total Liabilities | $56.4M | +90.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.2M | -30.0% |
| Capital Expenditures | $423K | -76.2% |
| Investing Cash Flow | -$498K | +75.1% |
| Financing Cash Flow | $43.3M | +73.7% |
| Free Cash Flow | -$45.6M | -24.8% |
| -80.0% |
| EPS (Diluted) | -$0.45 | -80.0% |
| Stockholders' Equity |
| -$29.5M |
| -1075.6% |